Suppr超能文献

两个可能在质膜Ca(2+)-ATP酶跨膜结构域六中与Ca2+结合的残基。

Two residues that may ligate Ca2+ in transmembrane domain six of the plasma membrane Ca(2+)-ATPase.

作者信息

Adebayo A O, Enyedi A, Verma A K, Filoteo A G, Penniston J T

机构信息

Department of Biochemistry and Molecular Biology, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA.

出版信息

J Biol Chem. 1995 Nov 17;270(46):27812-6. doi: 10.1074/jbc.270.46.27812.

Abstract

In order to identify Ca2+ ligands in the putative transmembrane domain 6 of the plasma membrane Ca2+ pump, amino acids Asn879, Met882, Asp883, and Ser887 were singly altered. Asn879, Met882, and Asp883 were chosen because the corresponding amino acids have been proposed as Ca2+ ligands in the sarcoplasmic reticulum Ca2+ pump (Clarke, D. M., Loo, T. W., and MacLennan, D. H. (1990) J. Biol. Chem. 265, 6262-6267). For the alterations, a fully active truncated version of the pump was used, because the interaction of Ca2+ with the pump could be studied without interference from calmodulin binding. The mutants at Asn and Asp did not carry out ATP-supported Ca2+ uptake and formed no acylphosphate from [gamma-32P]ATP, suggesting that, like the corresponding amino acids in the sarcoplasmic reticulum Ca2+ pump, these two are Ca2+ ligands. However, all the mutants at the position of Met882 showed some activity. Indeed, the Met882--> Ile mutant was fully active at a saturating Ca2+ concentration and only the K1/2 for Ca2+ activation was shifted slightly upward. Converting the Met to Thr (which is the corresponding residue in the sarcoplasmic reticulum Ca2+ pump) reduced the activity to 20% of the wild type, further emphasizing the differences between the two Ca2+ pumps. The mutant Ser887--> Ala was expressed in greater amounts than, and had a specific activity about 50% higher than, the wild type, indicating that this serine also could not be a Ca2+ ligand and could not replace the missing Thr at position Met882.

摘要

为了鉴定质膜钙泵假定跨膜结构域6中的钙离子配体,对氨基酸Asn879、Met882、Asp883和Ser887进行了单一位点突变。选择Asn879、Met882和Asp883是因为在肌浆网钙泵中,相应的氨基酸已被认为是钙离子配体(Clarke, D. M., Loo, T. W., and MacLennan, D. H. (1990) J. Biol. Chem. 265, 6262 - 6267)。对于这些突变,使用了泵的一个完全活性的截短版本,因为这样可以在不受钙调蛋白结合干扰的情况下研究钙离子与泵的相互作用。Asn和Asp位点的突变体不能进行ATP支持的钙离子摄取,也不能从[γ - 32P]ATP形成酰基磷酸,这表明与肌浆网钙泵中的相应氨基酸一样,这两个氨基酸是钙离子配体。然而,Met882位点的所有突变体都表现出一定活性。实际上,Met882→Ile突变体在钙离子饱和浓度下完全有活性,只是钙离子激活的K1/2略有上移。将Met转换为Thr(这是肌浆网钙泵中的相应残基)会使活性降至野生型的20%,进一步强调了这两种钙泵之间的差异。突变体Ser887→Ala的表达量比野生型高,比活性比野生型高约50%,这表明该丝氨酸也不是钙离子配体,不能替代Met882位点缺失的Thr。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验